A cross-sectional study of 3,855 blood donors in southern Mozambique found anti-HDV antibodies in one HBsAg-negative donor ...
Flow Space on MSN
6 breast cancer innovations changing the face of disease
From AI risk assessment to tests that help you choose the best course of treatment, breast cancer innovations are moving us ...
Spread the loveImagine your phone rings. You pick it up, and on the other end, a voice you recognize – perhaps from a local ...
According to Belk, homeowners just ten years ago insisted on hardwood and tile throughout the home. Today, those same ...
MedPage Today on MSN
Psilocybin tied to lower inflammation in Parkinson's trial
Study provides first data about effects in any neurodegenerative disorder ...
Multi-lumen extrusion allows several functions to be incorporated into a single component, but it also creates significant ...
A new molecular classification framework reveals that oxidized organic compounds, rather than particle mass, govern the ...
Spread the love“`html It feels like just yesterday we were marveling at AI’s ability to create realistic images or translate ...
A simple daily blood test could help critically ill sepsis patients come off antibiotics sooner, potentially reducing drug ...
Test Apex Legends meta weapons in Season 30 with a Python TTK lab: Playground stats, patch diffs and source checks in 12 ...
Boost ROI with validated, automated multiplex assays, AI analytics and research partnerships that improve throughput, reproducibility and biomarker relevance.Dublin, Oct. 20, 2026 (GLOBE NEWSWIRE) -- ...
A Boston neuroscientist who has spent more than four decades chasing the genetic roots of Alzheimer's disease is now positioned to test whether a cheap daily pill could stop the disease before it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results